logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Oscient Pharmaceuticals Corporation

Calculating rank
USPTO Granted Patents = 18

% Expired Patents = 77.8


Forward Citations = 237

Loading Chart...
Loading Chart...

41 inventors (with patents filed for the assignee):

goldMedal Kristina Allen (10 out of 12 patents)

silverMedal Randall D Little (8 out of 13 patents)

bronzeMedal Richard Giulio Del Mastro (7 out of 9 patents)

4.  Jason Samuel Simon (7 out of 15 patents)

5.  Tim Keith (7 out of 9 patents)

6.  Paul Van Eerdewegh (7 out of 9 patents)

7.  Sunil D Pandit (7 out of 9 patents)

8.  Josée Dupuis (5 out of 5 patents)

9.  Anthony Anisowicz (3 out of 6 patents)

10.  Josèe Dupuis (2 out of 2 patents)

11.  Paul John Yaworsky (2 out of 4 patents)

12.  Wenhao Hu (2 out of 2 patents)

13.  Arturo Morales (2 out of 2 patents)

14.  David E Bush (2 out of 68 patents)

15.  Matthew Olson (1 out of 4 patents)


18 patents:

1. 8907067 - Nucleotide and amino acid sequences relating to respiratory diseases and obesity (2014-12-09),
2. 8124734 - Human genes relating to respiratory diseases and obesity (2012-02-28),
3. 8105826 - Nucleotide and amino acid sequences relating to respiratory diseases and obesity (2012-01-31),
4. 7928200 - Human genes relating to respiratory diseases and obesity (2011-04-19),
5. 7867699 - Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained thereby (2011-01-11),
6. 7700101 - Reagents and method for modulating Dkk-mediated interactions (2010-04-20),
7. 7642245 - Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif (2010-01-05),
8. 7517684 - [object Object] (2009-04-14),
9. 7504490 - [object Object] (2009-03-17),
10. 7501118 - Human gene relating to respiratory diseases and obesity (2009-03-10),
11. 7416849 - HBM variants that modulate bone mass and lipid levels (2008-08-26),
12. 7407804 - Human genes relating to respiratory diseases and obesity (2008-08-05),
13. 7317001 - Use of ramoplanin to treat diseases associated with the use of antibiotics (2008-01-08),
14. 7241613 - [object Object] (2007-07-10),
15. 7205146 - Nucleotide and amino acid sequences relating to respiratory diseases and obesity (2007-04-17),
Company Overview
Oscient Pharmaceuticals Corporation is a biopharmaceutical company based in Waltham, Massachusetts, specializing in the development of innovative therapies for various medical conditions. The organization focuses on addressing unmet medical needs through its research in drug discovery and development, particularly in the fields of infectious diseases and metabolic disorders. With a commitment to advancing healthcare solutions, Oscient aims to improve patient outcomes by leveraging cutting-edge science and technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

18 Patents

#81 in Waltham, MA

#1,103 in Massachusetts

#17,988 in US

#34,283 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Oscient Pharmaceuticals Corporation

Forward Citations = 237

41 inventors:

goldMedal Kristina Allen (10 out of 12 patents)

silverMedal Randall D Little (8 out of 13 patents)

bronzeMedal Richard Giulio Del Mastro (7 out of 9 patents)

4.  Jason Samuel Simon (7 out of 15 patents)

5.  Tim Keith (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oscient Pharmaceuticals Corporation. Retrieved from https://idiyas.com/company/oscient-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…